Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongming Qu

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Statistics in Medicine|April 17, 2013
Sensitivity in statistical evaluation of biomarkersWen Li, Yongming Qu, Pandurang M Kulkarni
Therapeutic Innovation & Regulatory Science|December 21, 2022
Accurate Collection of Reasons for Treatment Discontinuation to Better Define Estimands in Clinical TrialsYongming Qu, Robin D White, Stephen J Ruberg
Pharmaceutical Statistics|March 1, 2012
A Bayesian approach to the statistical analysis of device preference studiesHaoda Fu, Yongming Qu, Baojin Zhu, et al.
Statistics in Medicine|September 17, 2020
Understanding and adjusting for the selection bias from a proof-of-concept study to a more confirmatory studyYongming Qu, Yu Du, Ying Zhang, et al.
Therapeutic Innovation & Regulatory Science|June 18, 2026
Predicting the Treatment Regimen Estimand in Phase 3 Studies from the Estimated Efficacy Estimand Based on Phase 2 DataZhili Qiao, Yu Du, Jitong Lou, et al.
Statistics in Medicine|March 10, 2006
Estimating the response rate in the presence of measurement errorYongming Qu, Pandurang M Kulkarni, Todd M Sanger
Statistics in Medicine|May 14, 2024
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trialsYu Du, Jianghao Li, Sohini Raha, et al.
Pharmaceutical Statistics|March 12, 2022
Analysis of an incomplete binary outcome dichotomized from an underlying continuous variable in clinical trialsChenchen Ma, Xin Shen, Yongming Qu, et al.
Statistics in Medicine|November 17, 2011
A new classification approach for comparing two active treatments when there is no prior projection on which one is betterYongming Qu, Rong Liu, Alexei Dmitrienko, et al.
Pharmaceutical Statistics|April 7, 2020
Estimation of group means in generalized linear mixed modelsJiexin Duan, Michael Levine, Junxiang Luo, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Statistics in Medicine|April 17, 2013
Sensitivity in statistical evaluation of biomarkersWen Li, Yongming Qu, Pandurang M Kulkarni
Therapeutic Innovation & Regulatory Science|December 21, 2022
Accurate Collection of Reasons for Treatment Discontinuation to Better Define Estimands in Clinical TrialsYongming Qu, Robin D White, Stephen J Ruberg
Pharmaceutical Statistics|March 1, 2012
A Bayesian approach to the statistical analysis of device preference studiesHaoda Fu, Yongming Qu, Baojin Zhu, et al.
Statistics in Medicine|September 17, 2020
Understanding and adjusting for the selection bias from a proof-of-concept study to a more confirmatory studyYongming Qu, Yu Du, Ying Zhang, et al.
Therapeutic Innovation & Regulatory Science|June 18, 2026
Predicting the Treatment Regimen Estimand in Phase 3 Studies from the Estimated Efficacy Estimand Based on Phase 2 DataZhili Qiao, Yu Du, Jitong Lou, et al.
Statistics in Medicine|March 10, 2006
Estimating the response rate in the presence of measurement errorYongming Qu, Pandurang M Kulkarni, Todd M Sanger
Statistics in Medicine|May 14, 2024
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trialsYu Du, Jianghao Li, Sohini Raha, et al.
Pharmaceutical Statistics|March 12, 2022
Analysis of an incomplete binary outcome dichotomized from an underlying continuous variable in clinical trialsChenchen Ma, Xin Shen, Yongming Qu, et al.
Statistics in Medicine|November 17, 2011
A new classification approach for comparing two active treatments when there is no prior projection on which one is betterYongming Qu, Rong Liu, Alexei Dmitrienko, et al.
Pharmaceutical Statistics|April 7, 2020
Estimation of group means in generalized linear mixed modelsJiexin Duan, Michael Levine, Junxiang Luo, et al.
Pageof 8